| Simultaneous humoral and cellular immune response against cancer–testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2–binding peptide epitopes E Jäger, YT Chen, JW Drijfhout, J Karbach, M Ringhoffer, D Jäger, ... The Journal of experimental medicine 187 (2), 265-270, 1998 | 938 | 1998 |
| A survey of the humoral immune response of cancer patients to a panel of human tumor antigens E Stockert, E Jäger, YT Chen, MJ Scanlan, I Gout, J Karbach, M Arand, ... The Journal of experimental medicine 187 (8), 1349-1354, 1998 | 909 | 1998 |
| Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers E Jäger, S Gnjatic, Y Nagata, E Stockert, D Jäger, J Karbach, A Neumann, ... Proceedings of the National Academy of Sciences 97 (22), 12198-12203, 2000 | 603 | 2000 |
| A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathioneS-transferase GSTM1 and GSTT1 polymorphisms M Arand, R Mühlbauer, J Hengstler, E Jäger, J Fuchs, L Winkler, F Oesch Analytical biochemistry 236 (1), 184-186, 1996 | 448 | 1996 |
| Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma E Jäger, M Ringhoffer, M Altmannsberger, M Arand, J Karbach, D Jäger, ... International journal of cancer 71 (2), 142-147, 1997 | 409 | 1997 |
| Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses E Jager, Y Nagata, S Gnjatic, H Wada, E Stockert, J Karbach, PR Dunbar, ... Proceedings of the National Academy of Sciences of the United States of …, 2000 | 395 | 2000 |
| Granulocyte‐macrophage‐colony‐stimulating factor enhances immune responses to melanoma‐associated peptides in vivo E Jäger, M Ringhoffer, HP Dienes, M Arand, J Karbach, D Jäger, ... International journal of cancer 67 (1), 54-62, 1996 | 376 | 1996 |
| Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic‐T‐cell responses: Evidence for immunoselection of antigen … E Jäger, M Ringhoffer, J Karbach, M Arand, F Oesch, A Knuth International Journal of Cancer 66 (4), 470-476, 1996 | 363 | 1996 |
| Generation of cytotoxic T‐cell responses with synthetic melanoma‐associated peptides in vivo: Implications for tumor vaccines with melanoma‐associated antigens E Jäeger, H Bernhard, P Romero, M Ringhoffer, M Arand, J Karbach, ... International journal of cancer 66 (2), 162-169, 1996 | 315 | 1996 |
| Humoral immune responses of cancer patients against “cancer‐testis” antigen NY‐ESO‐1: correlation with clinical events E Jäger, E Stockert, Z Zidianakis, YT Chen, J Karbach, D Jäger, M Arand, ... International journal of cancer 84 (5), 506-510, 1999 | 307 | 1999 |
| Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility JG Hengstler, M Arand, ME Herrero, F Oesch Genes and environment in cancer, 47-85, 1998 | 306 | 1998 |
| Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients … E Jäger, D Jäger, J Karbach, YT Chen, G Ritter, Y Nagata, S Gnjatic, ... The Journal of Experimental Medicine 191 (4), 625-630, 2000 | 275 | 2000 |
| Mammalian epoxide hydrolases in xenobiotic metabolism and signalling M Decker, M Arand, A Cronin Archives of toxicology 83, 297-318, 2009 | 251 | 2009 |
| Structure of Aspergillus niger epoxide hydrolase at 1.8 Å resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases J Zou, BM Hallberg, T Bergfors, F Oesch, M Arand, SL Mowbray, TA Jones Structure 8 (2), 111-122, 2000 | 238 | 2000 |
| Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways B Oesch-Bartlomowicz, A Huelster, O Wiss, P Antoniou-Lipfert, C Dietrich, ... Proceedings of the National Academy of Sciences 102 (26), 9218-9223, 2005 | 227 | 2005 |
| Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins: implication for the potential catalytic mechanism of … M Arand, DF Grant, JK Beetham, T Friedberg, F Oesch, BD Hammock FEBS letters 338 (3), 251-256, 1994 | 223 | 1994 |
| Enhancing the enantioselectivity of an epoxide hydrolase by directed evolution MT Reetz, C Torre, A Eipper, R Lohmer, M Hermes, B Brunner, ... Organic letters 6 (2), 177-180, 2004 | 201 | 2004 |
| Gene evolution of epoxide hydrolases and recommended nomenclature JK Beetham, D Grant, M Arand, J Garbarino, T Kiyosue, F PINOT, ... DNA and cell biology 14 (1), 61-71, 1995 | 190 | 1995 |
| The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase A Cronin, S Mowbray, H Dürk, S Homburg, I Fleming, B Fisslthaler, ... Proceedings of the national academy of sciences 100 (4), 1552-1557, 2003 | 177 | 2003 |
| Structure of Rhodococcus erythropolis limonene‐1, 2‐epoxide hydrolase reveals a novel active site M Arand, BM Hallberg, J Zou, T Bergfors, F Oesch, MJ van der Werf, ... The EMBO journal, 2003 | 176 | 2003 |
